Rockwell Medical Technologies (NASDAQ: RMTI) reported Q3 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $11.98 million versus the consensus estimate of $12.03 million.

Earnings